The ethics and legality of HIV seroprevalence studies.
Sharpe
G
G
Ontario Ministry of Health.
D015492:AIDS Serodiagnosis / Q000592:standards*; D035041:Anonymous Testing; D001634:Bibliographies as Topic; D002985:Clinical Protocols; D003142:Communication; D003256:Community Participation / Q000331:legislation & jurisprudence; D030881:Disclosure; D017007:Duty to Warn / Q000331:legislation & jurisprudence; D026724:Ethical Review; D004991:Ethics, Institutional; D004992:Ethics, Medical; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000453:epidemiology; D015528:HIV Seroprevalence; D006801:Humans; D007231:Infant, Newborn; D033181:Information Dissemination; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D009035:Mothers / Q000331:legislation & jurisprudence; D015997:Neonatal Screening / Q000592:standards*; D009864:Ontario / Q000453:epidemiology; D033282:Parental Consent; D026684:Personal Autonomy; D011247:Pregnancy; D037841:Pregnant People; D012106:Research / Q000592:standards; D012107:Research Design / Q000592:standards; D035842:Research Subjects; D018570:Risk Assessment; D014342:Truth Disclosure